Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy helps heal pediatric surgical wounds faster and with fewer scars but needs more research for safety and cost.

Cosmetics can contain harmful chemicals that may cause health issues.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

A blood pressure drug, diltiazem, may also help treat influenza.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.